Loading...
New Therapeutics to Treat Castrate-Resistant Prostate Cancer
The effective treatment of castrate-resistant prostate cancer (CRPC) has proven to be very challenging. Until recently, docetaxel was the only therapeutic demonstrated to extend overall patient survival. Yet recently, a considerable number of new therapeutics have been approved to treat CRPC patient...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3678432/ https://ncbi.nlm.nih.gov/pubmed/23781155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/379641 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|